Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3687864013 | Product containing loteprednol and tobramycin (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3715551014 | Loteprednol- and tobramycin-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Loteprednol- and tobramycin-containing product | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
| Loteprednol- and tobramycin-containing product | Is a | Tobramycin-containing product | true | Inferred relationship | Some | ||
| Loteprednol- and tobramycin-containing product | Has active ingredient | Tobramycin | true | Inferred relationship | Some | 1 | |
| Loteprednol- and tobramycin-containing product | Has active ingredient | Loteprednol | true | Inferred relationship | Some | 2 | |
| Loteprednol- and tobramycin-containing product | Is a | Loteprednol-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Loteprednol and tobramycin only product | Is a | True | Loteprednol- and tobramycin-containing product | Inferred relationship | Some | |
| Loteprednol- and tobramycin-containing product in ocular dose form | Is a | True | Loteprednol- and tobramycin-containing product | Inferred relationship | Some | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Is a | False | Loteprednol- and tobramycin-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR